APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tadalafil Oral

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tadalafil Oral Industry Growth and Trends Forecast to 2032

22 December 2025102 pages

Choose your research edition.

Industry ResearchTadalafil Oral Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Tadalafil Oral Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Tadalafil Oral Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tadalafil Oral Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Tadalafil Oral Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tadalafil Oral market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tadalafil Oral is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tadalafil Oral is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tadalafil Oral is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tadalafil Oral include Teva, Sun Pharma, Qilu Pharmaceutical, Mylan, Eli Lilly, Dr. Reddys Laboratories, Cipla, Aurobindo and Alembic Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tadalafil Oral market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tadalafil Oral market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tadalafil Oral market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tadalafil Oral.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tadalafil Oral market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tadalafil Oral Market by Company

Teva

Sun Pharma

Qilu Pharmaceutical

Mylan

Eli Lilly

Dr. Reddys Laboratories

Cipla

Aurobindo

Alembic Pharmaceuticals

Ajanta Pharma Ltd.

Tadalafil Oral Segment by Type

5 mg tablets

20 mg tablets

2.5 mg tablets

10mg tablets

Tadalafil Oral Segment by Application

Hospital

Drug store

Tadalafil Oral Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tadalafil Oral market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tadalafil Oral and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tadalafil Oral.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tadalafil Oral manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tadalafil Oral in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5 mg tablets Table 2. Major Company of 20 mg tablets Table 3. Major Company of 2.5 mg tablets Table 4. Major Company of 10mg tablets Table 5. Global Tadalafil Oral Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Tadalafil Oral Sales by Type (2021-2026) & (k units) Table 7. Global Tadalafil Oral Sales Market Share in Volume by Type (2021-2026) Table 8. Global Tadalafil Oral Sales by Type (2021-2026) & (US$ Million) Table 9. Global Tadalafil Oral Sales Market Share in Value by Type (2021-2026) Table 10. Global Tadalafil Oral Price by Type (2021-2026) & (US$/unit) Table 11. Global Tadalafil Oral Sales by Type (2027-2032) & (k units) Table 12. Global Tadalafil Oral Sales Market Share in Volume by Type (2027-2032) Table 13. Global Tadalafil Oral Sales by Type (2027-2032) & (US$ Million) Table 14. Global Tadalafil Oral Sales Market Share in Value by Type (2027-2032) Table 15. Global Tadalafil Oral Price by Type (2027-2032) & (US$/unit) Table 16. North America Tadalafil Oral Sales by Type (2021-2026) & (k units) Table 17. North America Tadalafil Oral Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Tadalafil Oral Sales by Type (2021-2026) & (k units) Table 19. Europe Tadalafil Oral Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Tadalafil Oral Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Tadalafil Oral Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Tadalafil Oral Sales by Type (2021-2026) & (k units) Table 23. Latin America Tadalafil Oral Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Tadalafil Oral Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Tadalafil Oral Sales by Type (2021-2026) & (US$ Million) Table 26. Tadalafil Oral Industry Trends Table 27. Tadalafil Oral Industry Drivers Table 28. Tadalafil Oral Industry Opportunities and Challenges Table 29. Tadalafil Oral Industry Restraints Table 30. Global Tadalafil Oral Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Tadalafil Oral Revenue Market Share by Company (2021-2026) Table 32. Global Tadalafil Oral Sales by Company (2021-2026) & (k units) Table 33. Global Tadalafil Oral Sales Share by Company (2021-2026) Table 34. Global Tadalafil Oral Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Tadalafil Oral Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Tadalafil Oral Major Company Production Sites and Headquarters Table 37. Global Tadalafil Oral Company, Product Type & Application Table 38. Global Tadalafil Oral Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Tadalafil Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Tadalafil Oral Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Tadalafil Oral Sales by Region (2021-2026) & (k units) Table 43. Global Tadalafil Oral Sales Market Share in Volume by Region (2021-2026) Table 44. Global Tadalafil Oral Sales by Region (2021-2026) & (US$ Million) Table 45. Global Tadalafil Oral Sales Market Share in Value by Region (2021-2026) Table 46. Global Tadalafil Oral Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Tadalafil Oral Sales by Region (2027-2032) & (k units) Table 48. Global Tadalafil Oral Sales Market Share in Volume by Region (2027-2032) Table 49. Global Tadalafil Oral Sales by Region (2027-2032) & (US$ Million) Table 50. Global Tadalafil Oral Sales Market Share in Value by Region (2027-2032) Table 51. Global Tadalafil Oral Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Tadalafil Oral Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Tadalafil Oral Sales by Application (2021-2026) & (k units) Table 54. Global Tadalafil Oral Sales Market Share in Volume by Application (2021-2026) Table 55. Global Tadalafil Oral Sales by Application (2021-2026) & (US$ Million) Table 56. Global Tadalafil Oral Sales Market Share in Value by Application (2021-2026) Table 57. Global Tadalafil Oral Price by Application (2021-2026) & (US$/unit) Table 58. Global Tadalafil Oral Sales by Application (2027-2032) & (k units) Table 59. Global Tadalafil Oral Sales Market Share in Volume by Application (2027-2032) Table 60. Global Tadalafil Oral Sales by Application (2027-2032) & (US$ Million) Table 61. Global Tadalafil Oral Sales Market Share in Value by Application (2027-2032) Table 62. Global Tadalafil Oral Price by Application (2027-2032) & (US$/unit) Table 63. North America Tadalafil Oral Sales by Application (2021-2026) & (k units) Table 64. North America Tadalafil Oral Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Tadalafil Oral Sales by Application (2021-2026) & (k units) Table 66. Europe Tadalafil Oral Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Tadalafil Oral Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Tadalafil Oral Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Tadalafil Oral Sales by Application (2021-2026) & (k units) Table 70. Latin America Tadalafil Oral Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Tadalafil Oral Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Tadalafil Oral Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Tadalafil Oral Product Portfolio Table 77. Teva Recent Development Table 78. Sun Pharma Company Information Table 79. Sun Pharma Business Overview Table 80. Sun Pharma Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sun Pharma Tadalafil Oral Product Portfolio Table 82. Sun Pharma Recent Development Table 83. Qilu Pharmaceutical Company Information Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Qilu Pharmaceutical Tadalafil Oral Product Portfolio Table 87. Qilu Pharmaceutical Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Mylan Tadalafil Oral Product Portfolio Table 92. Mylan Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Eli Lilly Tadalafil Oral Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Dr. Reddys Laboratories Company Information Table 99. Dr. Reddys Laboratories Business Overview Table 100. Dr. Reddys Laboratories Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Dr. Reddys Laboratories Tadalafil Oral Product Portfolio Table 102. Dr. Reddys Laboratories Recent Development Table 103. Cipla Company Information Table 104. Cipla Business Overview Table 105. Cipla Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Cipla Tadalafil Oral Product Portfolio Table 107. Cipla Recent Development Table 108. Aurobindo Company Information Table 109. Aurobindo Business Overview Table 110. Aurobindo Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Aurobindo Tadalafil Oral Product Portfolio Table 112. Aurobindo Recent Development Table 113. Alembic Pharmaceuticals Company Information Table 114. Alembic Pharmaceuticals Business Overview Table 115. Alembic Pharmaceuticals Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Alembic Pharmaceuticals Tadalafil Oral Product Portfolio Table 117. Alembic Pharmaceuticals Recent Development Table 118. Ajanta Pharma Ltd. Company Information Table 119. Ajanta Pharma Ltd. Business Overview Table 120. Ajanta Pharma Ltd. Tadalafil Oral Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Ajanta Pharma Ltd. Tadalafil Oral Product Portfolio Table 122. Ajanta Pharma Ltd. Recent Development Table 123. North America Tadalafil Oral Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. North America Tadalafil Oral Sales by Country (2021-2026) & (k units) Table 125. North America Tadalafil Oral Sales Market Share by Country (2021-2026) Table 126. North America Tadalafil Oral Sales Forecast by Country (2027-2032) & (k units) Table 127. North America Tadalafil Oral Sales Market Share Forecast by Country (2027-2032) Table 128. North America Tadalafil Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Tadalafil Oral Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Tadalafil Oral Market Share by Country (2021-2026) Table 131. North America Tadalafil Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Tadalafil Oral Market Share Forecast by Country (2027-2032) Table 133. Europe Tadalafil Oral Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Europe Tadalafil Oral Sales by Country (2021-2026) & (k units) Table 135. Europe Tadalafil Oral Sales Market Share by Country (2021-2026) Table 136. Europe Tadalafil Oral Sales Forecast by Country (2027-2032) & (k units) Table 137. Europe Tadalafil Oral Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Tadalafil Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Tadalafil Oral Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Tadalafil Oral Market Share by Country (2021-2026) Table 141. Europe Tadalafil Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Tadalafil Oral Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Tadalafil Oral Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Tadalafil Oral Sales by Country (2021-2026) & (k units) Table 145. Asia-Pacific Tadalafil Oral Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Tadalafil Oral Sales Forecast by Country (2027-2032) & (k units) Table 147. Asia-Pacific Tadalafil Oral Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Tadalafil Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Tadalafil Oral Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Tadalafil Oral Market Share by Country (2021-2026) Table 151. Asia-Pacific Tadalafil Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Tadalafil Oral Market Share Forecast by Country (2027-2032) Table 153. Latin America Tadalafil Oral Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Latin America Tadalafil Oral Sales by Country (2021-2026) & (k units) Table 155. Latin America Tadalafil Oral Sales Market Share by Country (2021-2026) Table 156. Latin America Tadalafil Oral Sales Forecast by Country (2027-2032) & (k units) Table 157. Latin America Tadalafil Oral Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Tadalafil Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Tadalafil Oral Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Tadalafil Oral Market Share by Country (2021-2026) Table 161. Latin America Tadalafil Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Tadalafil Oral Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Tadalafil Oral Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Tadalafil Oral Sales by Country (2021-2026) & (k units) Table 165. Middle East and Africa Tadalafil Oral Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Tadalafil Oral Sales Forecast by Country (2027-2032) & (k units) Table 167. Middle East and Africa Tadalafil Oral Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Tadalafil Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Tadalafil Oral Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Tadalafil Oral Market Share by Country (2021-2026) Table 171. Middle East and Africa Tadalafil Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Tadalafil Oral Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Tadalafil Oral Distributors List Table 176. Tadalafil Oral Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Tadalafil Oral Image Figure 2. Global Tadalafil Oral Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tadalafil Oral Market Size (2021-2032) & (US$ Million) Figure 4. Global Tadalafil Oral Sales (2021-2032) & (k units) Figure 5. 5 mg tablets Image Figure 6. Global 5 mg tablets Sales YoY Growth (2021-2032) & (k units) Figure 7. 20 mg tablets Image Figure 8. Global 20 mg tablets Sales YoY Growth (2021-2032) & (k units) Figure 9. 2.5 mg tablets Image Figure 10. Global 2.5 mg tablets Sales YoY Growth (2021-2032) & (k units) Figure 11. 10mg tablets Image Figure 12. Global 10mg tablets Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Tadalafil Oral Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Tadalafil Oral Market Share by Type 2025 VS 2032 Figure 15. North America Tadalafil Oral Sales Market Share in Volume by Type in 2025 Figure 16. North America Tadalafil Oral Sales Market Share in Value by Type in 2025 Figure 17. Europe Tadalafil Oral Sales Market Share in Volume by Type in 2025 Figure 18. Europe Tadalafil Oral Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Tadalafil Oral Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Tadalafil Oral Sales Market Share in Value by Type in 2025 Figure 21. Latin America Tadalafil Oral Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Tadalafil Oral Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Tadalafil Oral Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Tadalafil Oral Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Tadalafil Oral Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Drug store Image Figure 30. Global Drug store Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Tadalafil Oral Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Tadalafil Oral Market Share by Application 2025 VS 2032 Figure 33. North America Tadalafil Oral Sales Market Share in Volume by Application in 2025 Figure 34. North America Tadalafil Oral Sales Market Share in Value by Application in 2025 Figure 35. Europe Tadalafil Oral Sales Market Share in Volume by Application in 2025 Figure 36. Europe Tadalafil Oral Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Tadalafil Oral Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Tadalafil Oral Sales Market Share in Value by Application in 2025 Figure 39. Latin America Tadalafil Oral Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Tadalafil Oral Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Tadalafil Oral Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Tadalafil Oral Sales Market Share in Value by Application in 2025 Figure 43. North America Tadalafil Oral Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Tadalafil Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Tadalafil Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Tadalafil Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tadalafil Oral Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Tadalafil Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Tadalafil Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Tadalafil Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tadalafil Oral Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Tadalafil Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Tadalafil Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Tadalafil Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tadalafil Oral Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Tadalafil Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tadalafil Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Tadalafil Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tadalafil Oral Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Tadalafil Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Tadalafil Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Tadalafil Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Tadalafil Oral Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Tadalafil Oral Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg tablets
  • 20 mg tablets
  • 2.5 mg tablets
  • 10mg tablets
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Sun Pharma
  • Qilu Pharmaceutical
  • Mylan
  • Eli Lilly
  • Dr. Reddys Laboratories
  • Cipla
  • Aurobindo
  • Alembic Pharmaceuticals
  • Ajanta Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tadalafil Oral Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tadalafil Oral Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tadalafil Oral Market by Type
  6. 1.3.1 5 mg tablets
  7. 1.3.2 20 mg tablets
  8. 1.3.3 2.5 mg tablets
  9. 1.3.4 10mg tablets
  10. 1.4 Global Tadalafil Oral Market Size by Type
  11. 1.4.1 Global Tadalafil Oral Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Tadalafil Oral Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Tadalafil Oral Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Tadalafil Oral Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Tadalafil Oral Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Tadalafil Oral Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Tadalafil Oral Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Tadalafil Oral Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tadalafil Oral Industry Trends
  2. 2.2 Tadalafil Oral Industry Drivers
  3. 2.3 Tadalafil Oral Industry Opportunities and Challenges
  4. 2.4 Tadalafil Oral Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tadalafil Oral Revenue (2021-2026)
  2. 3.2 Global Top Players by Tadalafil Oral Sales (2021-2026)
  3. 3.3 Global Top Players by Tadalafil Oral Price (2021-2026)
  4. 3.4 Global Tadalafil Oral Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tadalafil Oral Major Company Production Sites & Headquarters
  6. 3.6 Global Tadalafil Oral Company, Product Type & Application
  7. 3.7 Global Tadalafil Oral Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tadalafil Oral Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tadalafil Oral Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tadalafil Oral Tier 1, Tier 2, and Tier 3
4 Tadalafil Oral Regional Status and Outlook
  1. 4.1 Global Tadalafil Oral Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tadalafil Oral Historic Market Size by Region
  3. 4.2.1 Global Tadalafil Oral Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tadalafil Oral Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tadalafil Oral Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tadalafil Oral Forecasted Market Size by Region
  7. 4.3.1 Global Tadalafil Oral Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tadalafil Oral Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tadalafil Oral Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tadalafil Oral by Application
  1. 5.1 Tadalafil Oral Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Tadalafil Oral Market Size by Application
  5. 5.2.1 Global Tadalafil Oral Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Tadalafil Oral Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Tadalafil Oral Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Tadalafil Oral Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Tadalafil Oral Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Tadalafil Oral Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Tadalafil Oral Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Tadalafil Oral Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Tadalafil Oral Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharma
  8. 6.2.1 Sun Pharma Company Information
  9. 6.2.2 Sun Pharma Business Overview
  10. 6.2.3 Sun Pharma Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharma Tadalafil Oral Product Portfolio
  12. 6.2.5 Sun Pharma Recent Developments
  13. 6.3 Qilu Pharmaceutical
  14. 6.3.1 Qilu Pharmaceutical Company Information
  15. 6.3.2 Qilu Pharmaceutical Business Overview
  16. 6.3.3 Qilu Pharmaceutical Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharmaceutical Tadalafil Oral Product Portfolio
  18. 6.3.5 Qilu Pharmaceutical Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Tadalafil Oral Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Tadalafil Oral Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Dr. Reddys Laboratories
  32. 6.6.1 Dr. Reddys Laboratories Company Information
  33. 6.6.2 Dr. Reddys Laboratories Business Overview
  34. 6.6.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dr. Reddys Laboratories Tadalafil Oral Product Portfolio
  36. 6.6.5 Dr. Reddys Laboratories Recent Developments
  37. 6.7 Cipla
  38. 6.7.1 Cipla Company Information
  39. 6.7.2 Cipla Business Overview
  40. 6.7.3 Cipla Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cipla Tadalafil Oral Product Portfolio
  42. 6.7.5 Cipla Recent Developments
  43. 6.8 Aurobindo
  44. 6.8.1 Aurobindo Company Information
  45. 6.8.2 Aurobindo Business Overview
  46. 6.8.3 Aurobindo Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aurobindo Tadalafil Oral Product Portfolio
  48. 6.8.5 Aurobindo Recent Developments
  49. 6.9 Alembic Pharmaceuticals
  50. 6.9.1 Alembic Pharmaceuticals Company Information
  51. 6.9.2 Alembic Pharmaceuticals Business Overview
  52. 6.9.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alembic Pharmaceuticals Tadalafil Oral Product Portfolio
  54. 6.9.5 Alembic Pharmaceuticals Recent Developments
  55. 6.10 Ajanta Pharma Ltd.
  56. 6.10.1 Ajanta Pharma Ltd. Company Information
  57. 6.10.2 Ajanta Pharma Ltd. Business Overview
  58. 6.10.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ajanta Pharma Ltd. Tadalafil Oral Product Portfolio
  60. 6.10.5 Ajanta Pharma Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Tadalafil Oral Sales by Country
  2. 7.1.1 North America Tadalafil Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tadalafil Oral Sales by Country (2021-2026)
  4. 7.1.3 North America Tadalafil Oral Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tadalafil Oral Market Size by Country
  6. 7.2.1 North America Tadalafil Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tadalafil Oral Market Size by Country (2021-2026)
  8. 7.2.3 North America Tadalafil Oral Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tadalafil Oral Sales by Country
  2. 8.1.1 Europe Tadalafil Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tadalafil Oral Sales by Country (2021-2026)
  4. 8.1.3 Europe Tadalafil Oral Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tadalafil Oral Market Size by Country
  6. 8.2.1 Europe Tadalafil Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tadalafil Oral Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tadalafil Oral Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tadalafil Oral Sales by Country
  2. 9.1.1 Asia-Pacific Tadalafil Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tadalafil Oral Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tadalafil Oral Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tadalafil Oral Market Size by Country
  6. 9.2.1 Asia-Pacific Tadalafil Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tadalafil Oral Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tadalafil Oral Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tadalafil Oral Sales by Country
  2. 10.1.1 South America Tadalafil Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tadalafil Oral Sales by Country (2021-2026)
  4. 10.1.3 South America Tadalafil Oral Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tadalafil Oral Market Size by Country
  6. 10.2.1 South America Tadalafil Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tadalafil Oral Market Size by Country (2021-2026)
  8. 10.2.3 South America Tadalafil Oral Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tadalafil Oral Sales by Country
  2. 11.1.1 Middle East and Africa Tadalafil Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tadalafil Oral Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tadalafil Oral Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tadalafil Oral Market Size by Country
  6. 11.2.1 Middle East and Africa Tadalafil Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tadalafil Oral Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tadalafil Oral Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tadalafil Oral Value Chain Analysis
  2. 12.1.1 Tadalafil Oral Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tadalafil Oral Production Mode & Process
  7. 12.2 Tadalafil Oral Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tadalafil Oral Distributors
  10. 12.2.3 Tadalafil Oral Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst